SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration under Section 12(g) of
the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under
Sections 13 and 15(d) of the Securities Exchange Act of 1934.
Commission File Number: 0-26992
CARDIOVASCULAR DIAGNOSTICS, INC.
--------------------------------
(Exact name of registrant as specified in its charter)
5301 Departure Drive, Raleigh, North Carolina 27616 (919) 954-9871
------------------------------------------------------------------
(Address, including zip code, and telephone number, including area code,
of registrant's principal executive offices)
Common Stock, $.001 par value
-----------------------------
(Title of each class of securities governed by this Form)
None
----
(Titles of all other classes of securities for which a duty
to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [ X ] Rule 12h-3(b)(1)(i) [ X ]
Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 15d-6 [ ]
Approximate number of holders of record as of the certification or notice
date: 1
Pursuant to the requirements of the Securities Exchange Act of 1934,
CARDIOVASCULAR DIAGNOSTICS, INC., has caused this certification/notice to be
signed on its behalf by the undersigned duly authorized person.
DATE: December 2, 1998 BY: /s/ John P. Funkhouser
----------------------------------------------
John P. Funkhouser, President and CEO
